Skip to main content
. 2017 Jul 20;11(7):e0005779. doi: 10.1371/journal.pntd.0005779

Fig 2. Exclusivity of LAMP assay tested in purified DNA samples from T. rangeli, Leishmania major stocks and non-infected human DNA.

Fig 2

Top Panel. (A): Leishmania major DNA was tested at 1.0 x 101fg/ μL; (B) 1.0 x .102 fg/ μL; (C) 1.0 x 103 fg/ μL; (D) 1.0 x. 104 fg/ μL. T. rangeli DNA was tested (E) at 1.0 x 104 fg/ μL and (F) 1.0 x .103 fg/μL. Bottom Panel. (A): Mixture containing equal volumes of T. cruzi and Leishmania major DNA at 1.0 x 104 fg/μL. (B): Mixture containing equal volumes of T. cruzi and T. rangeli DNA at 1.0 x 104 fg/μL. (C): T. cruzi DNA tested at 10 fg/μL. (D) and (E): T. rangeli DNA tested at 10 and 100 fg/μL, respectively. NIHB: Non-infected human DNA. PC: Positive Control. NC: Negative Control.